A Cerebrospinal Fluid Synaptic Protein Biomarker for Prediction of Resilience Versus Decline in Alzheimer’s Disease

Top-Down Attention and Alzheimer’s Pathology Affect Cortical Selectivity During Learning, Influencing Episodic Memory in Older Adults

Multi-cohort cerebrospinal fluid proteomics identifies robust molecular signatures for asymptomatic and symptomatic Alzheimer’s disease

A single-cell atlas to map sex-specific gene-expression changes in blood upon neurodegeneration

18F-PI-2620 Tau PET is associated with cognitive and motor impairment in Lewy body disease

Post-translational modifications linked to preclinical Alzheimer’s disease-related pathological and cognitive changes

Nanolithium, a new treatment approach to Alzheimer’s disease: a review of existing evidence and clinical perspectives